University of Texas Southwestern Medical Center, Department of Ophthalmology, Dallas, Texas.
Invest Ophthalmol Vis Sci. 2014 Jan 2;55(1):33-42. doi: 10.1167/iovs.13-12611.
We tested the association between two intronic polymorphisms (CTG18.1 and rs613872) in TCF4 and Fuchs' endothelial corneal dystrophy (FECD), and analyzed their segregation patterns in families.
We recruited 120 unrelated Caucasian subjects with FECD and 100 controls. Available family members of probands were recruited. Genotyping of the single nucleotide polymorphism (SNP) rs613872 was performed using Sanger sequencing or real-time allelic discrimination assay. The trinucleotide repeat polymorphism, CTG18.1, was genotyped using a combination of short tandem repeat assay and triplet repeat primed PCR assay. The cytosine-thymine-guanine (CTG) repeat length of ≥40 was classified as an expanded CTG18.1 allele. Association of the two loci with FECD was evaluated. Segregation in 29 families was examined.
The two polymorphisms are in linkage disequilibrium (r(2) = 0.65 in cases and 0.31 in controls). Significant associations were found between FECD and rs613872 (P = 3.1 × 10(-17)), expanded CTG18.1 allele (P = 6.5 × 10(-25)), and their haplotypes (P = 5.9 × 10(-19)). The odds ratio (OR) of each copy of the rs613872 G allele for FECD was estimated to be 9.5 (95% confidence interval [CI], 5.1-17.5). The OR of each copy of the CTG18.1 expanded allele was estimated to be 32.3 (95% CI, 13.4-77.6). The expanded CTG 18.1 allele cosegregated with the trait in 52% (15/29) of families with complete penetrance and 10% (3/29) with incomplete penetrance.
We report, to our knowledge, the first independent replication of the expanded CTG 18.1 allele conferring significant risk for FECD (>30-fold increase). The expanded allele cosegregates with the trait with complete penetrance in a majority of families, but we also document cases of incomplete penetrance.
我们检测了 TCF4 基因内含子中的两个单核苷酸多态性(CTG18.1 和 rs613872)与 Fuchs 内皮角膜营养不良(FECD)之间的关联,并分析了它们在家族中的分离模式。
我们招募了 120 名无亲缘关系的白种人 FECD 患者和 100 名对照。招募了先证者的可利用的家族成员。采用 Sanger 测序或实时等位基因鉴别分析对 SNP rs613872 进行基因分型。使用短串联重复序列测定和三核苷酸重复引物 PCR 测定的组合对三核苷酸重复多态性 CTG18.1 进行基因分型。将胞嘧啶-胸腺嘧啶-鸟嘌呤(CTG)重复长度≥40 分类为扩展 CTG18.1 等位基因。评估了两个基因座与 FECD 的关联。检查了 29 个家庭的分离情况。
两个多态性处于连锁不平衡状态(病例中 r(2) = 0.65,对照中 r(2) = 0.31)。FECD 与 rs613872(P = 3.1×10(-17))、扩展 CTG18.1 等位基因(P = 6.5×10(-25))及其单倍型(P = 5.9×10(-19))之间存在显著关联。每个 rs613872 G 等位基因对 FECD 的优势比(OR)估计为 9.5(95%置信区间 [CI],5.1-17.5)。扩展 CTG18.1 等位基因的 OR 估计为 32.3(95%CI,13.4-77.6)。在 29 个具有完全外显率的家族中,有 52%(15/29)的家族中扩展 CTG18.1 等位基因与表型共分离,有 10%(3/29)的家族具有不完全外显率。
我们报告了已知的第一个与 FECD 显著相关的扩展 CTG18.1 等位基因(>30 倍增加)的独立重复。扩展等位基因在大多数家族中与表型完全共分离,但我们也记录了不完全外显率的病例。